![Stanley Erck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 450 186 $ al 31/07/2026
El Sr. Stanley C. Erck es presidente, director ejecutivo y director de Novavax, Inc. y director no ejecutivo independiente de MaxCyte, Inc. Es miembro del Consejo de Administración de Novavax, Inc., de la Fundación MdBio y de MaxCyte, Inc. Anteriormente, el Sr. Erck fue director independiente de BioCryst Pharmaceuticals, Inc., presidente, director ejecutivo y director de Iomai Corp., jefe de Asuntos Regulatorios Globales de Vacunas de Baxter International, Inc., vicepresidente de Desarrollo Corporativo de Integrated Genetics, Inc. y presidente, director ejecutivo y director de Procept, Inc. Se licenció en la Universidad de Illinois y obtuvo un MBA en la Escuela de Negocios Booth de la Universidad de Chicago.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MAXCYTE, INC. 0,4 % | 17/06/2026 | 428.749 ( 0,4 % ) | 450 186 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MAXCYTE, INC. | Director/Miembro de la Junta | 01/01/2005 |
Learning Undefeated, Inc.
 Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Director/Miembro de la Junta | 13/05/2009 |
| Empresas | Cargo | Fin |
|---|---|---|
| NOVAVAX, INC. | Director Ejecutivo | 23/01/2023 |
| BIOCRYST PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 03/12/2018 |
| IOMAI CORPORATION | Director Ejecutivo | 01/01/2008 |
Integrated Genetics, Inc.
 Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations | Corporate Officer/Principal | - |
Procept, Inc.
 Procept, Inc. Pharmaceuticals: MajorHealth Technology Develops manufactures & markets drugs | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
MaxCyte, Inc.
 MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Procept, Inc.
Procept, Inc. Pharmaceuticals: MajorHealth Technology Develops manufactures & markets drugs | Health Technology |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intercell USA, Inc.
 Intercell USA, Inc. BiotechnologyHealth Technology Discovers and develops vaccines and immune system stimulants | Health Technology |
Integrated Genetics, Inc.
Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations | Health Technology |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Learning Undefeated, Inc.
Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
